REFERENCES
  1. Benjamin EJ., et al., Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98:946 – 52.
  2. Ball J, Carrington MJ, McMurray JJ, Steart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol 2013;167:1807 – 24.
  3. Wazni, O.M., et al., Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA, 2005. 293 (21): p. 2634-40.
  4. Wilber, D.J., et al., Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA, 2010.303 (4): p. 333-40
  5. Arora, S., et al., Causes and Predictors of Readmission in Patients With Atrial Fibrillation Undergoing Catheter Ablation: A National Population-Based Cohort Study. J Am Heart Assoc, 2018.7 (12).
  6. Garg, J., et al., Predictors of 30-day readmissions after catheter ablation for atrial fibrillation in the USA. J Interv Card Electrophysiol, 2019.
  7. Huang, H.D., et al., Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter. Europace, 2016. 18 (4): p. 521-30.
  8. Ikenaga, H., et al., Radiofrequency catheter ablation is effective for atrial fibrillation patients with hypertrophic cardiomyopathy by decreasing left atrial pressure. J Arrhythm, 2017.33 (4): p. 256-261.
  9. Joy, P.S., R. Gopinathannair, and B. Olshansky, Effect of Ablation for Atrial Fibrillation on Heart Failure Readmission Rates.Am J Cardiol, 2017. 120 (9): p. 1572-1577.
  10. Srivatsa, U.N., et al., California Study of Ablation for Atrial Fibrillation:Re-hospitalization for Cardiac Events (CAABL-CE). J Atr Fibrillation, 2018. 11 (1): p. 2036.
  11. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol . 2003; 91:2D– 8D.
  12. Anter, E., et al., Atrial Fibrillation and Heart Failure Treatment Considerations for a Dual Epidemic. Circ 2009. 119: p. 2516-25.
  13. Evranos, B., et al., Increased left atrial pressure predicts recurrence following successful cryoablation for atrial fibrillation with second-generation cryoballoon. J Interv Card Electrophysiol, 2016. 46 (2): p. 145-51.
  14. Kishima, H., et al., The Impact of Elevated Left Atrial Pressure in Sinus Rhythm After Cardioversion on Outcomes After Catheter Ablation for Atrial Fibrillation. J Cardiovasc Electrophysiol, 2016.27 (7): p. 813-9.
  15. Kishima, H., et al., Left atrial pressure pattern without a-wave in sinus rhythm after cardioversion affects the outcomes after catheter ablation for atrial fibrillation. Heart Vessels, 2018.33 (11): p. 1365-1372.
  16. Park, J., et al., Low Left Atrial Compliance Contributes to the Clinical Recurrence of Atrial Fibrillation after Catheter Ablation in Patients with Structurally and Functionally Normal Heart. PLoS One, 2015. 10 (12): p. e0143853.
  17. Sramko, M., et al., Resting and Exercise-Induced Left Atrial Hypertension in Patients With Atrial Fibrillation: The Causes and Implications for Catheter Ablation. JACC Clin Electrophysiol, 2017.3 (5): p. 461-469.
  18. Poole-Wilson PA, Buller NP. Causes of symptoms in chronic congestive heart failure and implications for treatment.  American Journal of Cardiology 1988. 62 31A–34A.
  19. Lehman, A., et al., Avoiding Urinary Catheterization in Patients Undergoing Atrial Fibrillation Catheter Ablation. J Afib, 2019-2020.12 (4): p. 12-15.
  20. Ahmed, A., et al., Avoiding Bladder Catheterization During Atrial Fibrillation Ablations. J Am Coll Cardiol EP, 2020.6 (2): p. 185-190.
  21. Lal, s., et al,. Acute Haemodynamic Effects of Frusemide in Patients with Normal and Raised Left Atrial Pressure. Brit Heart J 1969 31 : p. 711-717.